The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB),
including but not limited to those available through the PAAB Forum, the PAAB website, and any PAAB
correspondences, are specifically intended to assist individuals navigating the PAAB preclearance system.
Repurposing or reproducing this content without written consent from the PAAB Commissioner is strictly
prohibited. This prohibition includes, but is not limited to, use in machine learning or AI models.
74 - When a new company purchases an existing brand with existing PAAB approved marketing materials, do we need to resubmit those materials if the only changes relate to corporate ownership and the replacement PI?
FYI post-approval change/preclearance exemption/what requires review/PAAB scope
1
Posts
1
Posters
280
Views
1
Watching
-
You do not have to submit the files for a review unless the twelve month clearance period has expired. The PAAB does appreciate receiving notification that the brand has changed ownership in case we receive complaints about the advertising. Beyond the scope of the PAAB Code, you would have to respect legal requirements of declaring proper ownership on the advertising pieces.
